Rationale and study design of dietary intervention in patients polypectomized for tumors of the colorectum

Japanese Journal of Clinical Oncology

Volumn 32, Issue 12, 2002, Pages 550-553

  Tokudome, Shinkan ^a   Yokoyama, Y Yoshifumi ^a   Kamiya, Takeshi ^a   Seno, Kyoji ^a   Okuyama, Harumi ^b   Kuriki, Kiyonori ^a   Cheng, Jinglei ^a   Nakamura, Takaaki ^a   Fujii, Toshiko ^a   Ichikawa, Hiromitsu ^a   Itoh, Makoto ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Colorectal tumors; Dietary intervention; n 3 polyunsaturated fatty acids; Polypectomized patients; Randomized controlled trial

Indexed keywords

FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; FISH OIL; UNSATURATED FATTY ACID;

ARTICLE; CANCER GRADING; CANCER INHIBITION; CANCER SIZE; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; ERYTHROCYTE MEMBRANE; FAT CONTENT; FAT INTAKE; FATTY ACID BLOOD LEVEL; FOLLOW UP; FOOD SAFETY; HUMAN; LIPID ANALYSIS; LIPID DIET; LOW FAT DIET; PATIENT COMPLIANCE; PATIENT MONITORING; POLYPECTOMY; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIGMOID; ADENOCARCINOMA; ADENOMA; COLON POLYP; COLORECTAL TUMOR; COMPARATIVE STUDY; DIET; INTERVENTION STUDY; METHODOLOGY; MULTICENTER STUDY;

ADENOCARCINOMA; ADENOMA; COLONIC POLYPS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIET; DIETARY FATS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; FISH OILS; HUMANS; INTERVENTION STUDIES; RESEARCH DESIGN;

EID: 0036981479     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyf108     Document Type: Article

References (15)

1. Potter JD. Colorectal cancer: Molecules and populations. J Natl Cancer Inst 1999;91:916-32.
2. de Deckere EAM. Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer. Eur J Cancer Prev 1999; 8:213-21.
3. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999;83:217-44.
4. Takahashi M, Minamoto T, Yamashita N, Kato T, Yazawa K, Esumi H. Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Lett 1994;83:177-84.
5. Chen ZY, Istfan NW. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukotr Essent Fatty Acids 2000;63:301-8.
6. 2 release in healthy subjects. Gastroenterology 1993;105: 1317-22.
7. Anti M, Armelao F, Marra G, Percesepe A, Bartoli GM, Palozza P, et al. Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 1994;107:1709-18.
8. Huang Y-C, Jessup JM, Forse RA, Flickner S, Pleskow D, Anastopoulos HT, et al. n-3 fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa. Lipids 1996;31:S313-S317.
9. 2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer. Cancer Epidemiol Biomark Prev 2001;10:447-53.
10. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
11. Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, et al. Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 2000;60:4705-8.
12. Okuyama H. High n-6 to n-3 ratio of dietary fatty acids rather than serum cholesterol as a major risk factor for coronary heart disease. Eur J Lipid Sci Technol 2001;103:418-22.
13. Japanese Society for Cancer of the Colon and Rectum. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus, 6th ed. Tokyo: Kimbara-Shuppan 1998.
14. Zelen M. A new design for randomized clinical trials. N Engl J Med 1979; 300:1242-5.
15. Lipkin M. Colon cancer: A USA viewpoint. In: Hakama M, Beral V, Buiatti E, Faivre J, Parkin DM, editors. Chemoprevention in Cancer Control. Lyon: International Agency for Research on Cancer 1996;53-61.